Mercado global de externalização de assuntos regulamentares de saúde – Tendências do setor e previsão para 2028

Análise e insights do mercado de outsourcing de assuntos regulamentares de saúde

Espera-se que o mercado de outsourcing de assuntos regulamentares de saúde ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa o mercado para atingir um valor estimado de 9.651,3 milhões de dólares e crescer a um CAGR de 10,71% no período de previsão referido. O aumento das atividades de expansão geográfica por parte das empresas que procuram aprovações rápidas nos mercados globais impulsiona o mercado de externalização de assuntos regulamentares de saúde.

A externalização de assuntos regulamentares de saúde é o tipo de política regulamentar que é implementada para garantir que as empresas cumprem determinados padrões de funcionamento em relação aos seus negócios. Estas políticas visam, de um modo geral, salvaguardar a saúde e o bem-estar públicos, garantindo a segurança dos produtos farmacêuticos e de saúde. A externalização de assuntos regulamentares de saúde inclui frequentemente a redação médica e a publicação de documentação regulamentar oferecida por redatores médicos experientes, controlo de qualidade e editores que desempenham um papel importante no desenvolvimento de documentos de alta qualidade para projetos de investigação clínica.

Rising prevalence of numerous chronic diseases such as cancer and other infectious diseases have encouraged biopharmaceutical companies to develop a large number of new products which acts as the vital factor escalating the market growth, also increasing development of products in clinical trials, increase in the research and development activities, clinical trial applications, product registration, and drug pipeline, rising shift toward outcome-based model, increase in the use of generics, and increasing demand for drugs and medical devices at a lesser price, are the major factors among others driving the healthcare regulatory affairs outsourcing market. Moreover, increasing investments in the healthcare sector in developed and developing countries, and rising collaborations between regulatory outsourcing and drug developers will further create new opportunities for healthcare regulatory affairs outsourcing market in the forecast period of 2021-2028.

However, increasing approval time of a drug or device is a time taking process and is also a very expensive process which acts as the major factors among others which will obstruct the market growth, and will further challenge the growth of healthcare regulatory affairs outsourcing market in the forecast period mentioned above.

Healthcare regulatory affairs outsourcing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on healthcare regulatory affairs outsourcing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Healthcare Regulatory Affairs Outsourcing Market Scope and Market Size

Healthcare regulatory affairs outsourcing market is segmented on the basis of services and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of service, healthcare regulatory affairs outsourcing market is segmented into regulatory writing and publishing, regulatory submissions, clinical trial applications and services registrations, regulatory consulting and legal representation and other regulatory affairs.
• The healthcare regulatory affairs outsourcing market is also segmented on the basis of end-user into mid-size pharmaceutical companies, large pharmaceutical companies, biotechnology companies, medical device companies and food and beverage companies.

Healthcare Regulatory Affairs Outsourcing Market Country Level Analysis

Healthcare regulatory affairs outsourcing market is analysed and market size insights and trends are provided by country, services and end-user as referenced above.

The countries covered in the healthcare regulatory affairs outsourcing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific dominates the healthcare regulatory affairs outsourcing market due to increasing low costs of labor and increased availability of a skilled workforce and rising number of clinical trials along with rising number of companies trying to enter markets in countries such as India and China in this region. North America and Europe are the expected regions in terms of growth in healthcare regulatory affairs outsourcing market due to increasing presence of two major international regulatory agencies in these regions.

The country section of the healthcare regulatory affairs outsourcing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Healthcare regulatory affairs outsourcing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for healthcare regulatory affairs outsourcing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the healthcare regulatory affairs outsourcing market. The data is available for historic period 2010 to 2019.

Análise do cenário competitivo e da externalização de assuntos regulamentares de saúde

O cenário competitivo do mercado de externalização de assuntos regulamentares de saúde fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados fornecidos acima estão apenas relacionados com o foco das empresas relacionado com o mercado de outsourcing de assuntos regulamentares de saúde.

Os principais players abordados no relatório de mercado de outsourcing de assuntos regulamentares de saúde são a Accell Clinical Research, LLC, Charles River Laboratories, Medwisdom, Lifesciences Private Limited., Medwisdom Lifesciences Private Limited, Indexim International., Clinilabs Inc, CRITERIUM, INC., Covance, Cardinal Health, Freyr, ICON plc, IQVIA, Medpace, Inc, Parexel International Corporation, PPD Inc, Promedica International, PRA Health Sciences e WuXi AppTec, entre outros players nacionais e globais. Os dados de quota de mercado estão disponíveis para a Global, América do Norte, Europa, Ásia-Pacífico (APAC), Médio Oriente e África (MEA) e América do Sul em separado. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-59759